George Kenneth Lloyd

USPTO Granted Patents = 12 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 8)

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 146(Granted Patents)

Location History:

Poway, CA (US) (2011 - 2021)
San Carlos, CA (US) (2022)
New York, NY (US) (2023 - 2024)

Company Filing History:

8 out of 21

Beyondspring Pharmaceuticals, Inc.

patents

3 out of 36

Nereus Pharmaceuticals, Inc.

patents

1 out of 1

Nereus Pharmacuticals, Inc.

patent

Years Active: 2011-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12458638 - Method of stimulating neutrophil survival and reducing neutropenia (2025-11-04),

2. 12433886 - Composition and method for reducing neutropenia (2025-10-07),

3. 11857522 - Compositions containing tucaresol or its analogs (2024-01-02),

4. 11786523 - Composition and method for reducing thrombocytopenia (2023-10-17),

5. 11400086 - Method of reducing chemotherapy-induced neutropenia (2022-08-02),

6. 11229642 - Composition and method for reducing neutropenia (2022-01-25),

7. 10912748 - Compositions containing tucaresol or its analogs (2021-02-09),

8. 8618292 - Analogs of dehydrophenylahistins and their therapeutic use (2013-12-31),

9. 8247552 - Analogs of dehydrophenylahistins and their therapeutic use (2012-08-21),

10. 8129527 - Analogs of dehydrophenylahistins and their therapeutic use (2012-03-06),

11. 7935704 - Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof (2011-05-03),

12. 7919497 - Analogs of dehydrophenylahistins and their therapeutic use (2011-04-05),

Title: Innovations of George Kenneth Lloyd

Introduction

George Kenneth Lloyd is a notable inventor based in Poway, California, with a remarkable portfolio of 11 patents. His work primarily focuses on advancements in cancer treatment and related medical therapies.

Latest Patents

Among his latest patents, one significant invention is a composition and method for reducing neutropenia. This method involves administering plinabulin to subjects undergoing chemotherapy or radiation therapy to mitigate the adverse effects of these treatments. Another important patent includes compositions containing tucaresol or its analogs, which are designed for treating cancer. This invention outlines methods for co-administering a compound of formula (I) alongside immune checkpoint inhibitors or plinabulin to enhance cancer treatment efficacy.

Career Highlights

Throughout his career, George Kenneth Lloyd has made substantial contributions to the pharmaceutical industry. He has worked with prominent companies such as Beyondspring Pharmaceuticals, Inc. and Nereus Pharmaceuticals, Inc., where he has played a crucial role in developing innovative therapies.

Collaborations

George has collaborated with several professionals in the field, including Ramon Mohanlal and Lan Huang, who is a distinguished woman in the industry.

Conclusion

George Kenneth Lloyd's innovative work in cancer treatment and his extensive patent portfolio highlight his significant contributions to medical science. His dedication to improving patient outcomes through research and collaboration continues to inspire advancements in the field.

This text is generated by artificial intelligence and may not be accurate.